Category: Editors’ Pick

Walgreens Launches Its Own Covid Variant Surveillance

Walgreens has launched its own Covid-19 surveillance system to help identify the spread of virus variants across the U.S.

This Startup Just Raised $150 Million To Improve Diagnosis Of GI Diseases

Iterative Scopes uses AI and computer vision to detect GI diseases such as Inflammatory Bowel Disease.

This Startup Just Raised $150 Million To Improve Diagnosis Of GI Diseases

Iterative Scopes uses AI and computer vision to detect GI diseases such as Inflammatory Bowel Disease.

What Employers Need To Know About Vaccine Mandates Following SCOTUS Ruling

With the Biden administration’s vaccine-and-testing mandate blocked, employment lawyers weigh in on the implications for employers.

Better Vaccines, New Treatments And More Tests: Healthcare Companies Reveal Covid Plans

Pfizer, Moderna, Regeneron and many other healthcare companies presented at the 40th annual J.P. Morgan Healthcare Conference and outlined their plans to continue fighting Covid this year.

When Should I Use A PCR Test Versus An At-Home Antigen Test For Covid-19?

Dr. Matt Binnicker, an expert in the diagnosis of infectious diseases, reviews scenarios where an at-home antigen test is a good option, and when to seek out a lab-based PCR.

Booster Shot Generates Antibodies Against Omicron And Delta Variants, Says Indian Vaccine Maker

Bharat Biotech has already distributed around 180 doses of its Covaxin in India and has exported or donated 3 million doses across the world.

Three Ways The U.S. Government Can Fight The Omicron Wave

Dr. Anand Parekh, chief medical advisor for the Bipartisan Policy Center, discusses how the U.S. can bolster its response to the spread of the omicron variant.

Medicare Won’t Pay For Controversial Alzheimer’s Drug Aduhelm Without A New Trial

In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer’s drug Adulhelm until it sees positive results from a government-approved trial.

AI Startup DeepScribe Raises $30 Million To Help Prevent Physician Burnout

The San Francisco-based startup uses AI to transcribe doctors’ interactions with their patients, which saves them an average of three hours of work a day.